Ho-ho-ho! Gather around, my curious elves, for a tale not of the North Pole, but of the fascinating world of medical science, where researchers embarked on a sleigh ride through the snowy fields of genetics and vascular health. This story unfolds with a group of 118 spirited adventurers, all hailing from the land of China, each bearing the challenge of moyamoya disease (MMD), a condition as mysterious as the Northern Lights themselves.

Before these brave souls ventured into the land of encephaloduroarteriosynangiosis (EDAS), a magical procedure not unlike our toy-making process, they offered a gift of blood from the anterior cubital vein, a place as hidden as Santa’s secret workshop. The wizards of science, wielding their high-throughput mass spectrometry wands, delved into the genetic secrets of these adventurers, focusing on the MTHFR rs9651118 spell, a charm known to influence the rivers of life flowing within them.

As the story goes, these adventurers were divided into three groups based on their genetic gifts: 53 with the TT genotype, carriers of the original spell; 33 with the TC genotype, bearing a half-altered charm; and 32 with the CC genotype, fully transformed by the magic of genetics. The levels of homocysteine (Hcy), a potion affecting the formation of life’s rivers, and endothelial progenitor cells (EPCs), tiny elves repairing the vascular pathways, were measured with the precision of elves counting Christmas presents.

Six months after their EDAS journey, a magical viewing through digital subtraction angiography, akin to Santa’s list-checking, revealed the formation of new pathways, graded by the Matsushima system, as if ranking the quality of milk and cookies left out on Christmas Eve.

Lo and behold, the genetic charm worked its magic! Those bearing the altered spells, TC and CC, had rivers flowing more freely, with more tiny elves (EPCs) at work, compared to the original TT spell carriers. The levels of the Hcy potion were lower in these adventurers, suggesting a smoother journey in forming new pathways.

In the end, my dear elves, this tale teaches us that the MTHFR rs9651118 polymorphism, much like the secret recipe for Santa’s favorite cookies, is a key ingredient in the magical process of building new vascular pathways after EDAS in MMD patients. A story of hope, genetics, and the magic of healing, reminding us that sometimes, the best gifts are those of health and discovery. Merry Science to all, and to all a good night!